We are live on
!
Find out more
OCA
OpenArc Corporate Advisory Portfolio holdings
AUM
$8.41B
This Fund
S&P 500
This Quarter
Est. Return
+16.96%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.41B
AUM Growth
+$1.42B
(+20%)
Cap. Flow
+$539M
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
33.46%
Holding
833
New
117
Increased
380
Reduced
255
Closed
44
Avg Time Held
1.6
quarters
Top 10 Avg Time Held
1.6
quarters
Top 20 Avg Time Held
1.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$173M |
| 2 |
Vanguard Russell 1000 Value ETF
VONV
|
+$55.3M |
| 3 |
iShares MSCI EAFE Value ETF
EFV
|
+$54M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$34.1M |
| 5 |
BlackRock Flexible Income ETF
BINC
|
+$28.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares A.I. Innovation and Tech Active ETF
BAI
|
+$119M |
| 2 |
TCW Transform Systems ETF
PWRD
|
+$57.9M |
| 3 |
iShares US Financial Services ETF
IYG
|
+$24.4M |
| 4 |
Roper Technologies
ROP
|
+$24.1M |
| 5 |
iShares US Consumer Staples ETF
IYK
|
+$16.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.82% |
| 2 | Technology | 16.24% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Healthcare | 3.98% |
| 5 | Industrials | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Vanguard Tax-Exempt Bond Index Fund
VTEB
$49.8B
| $1.36M | 0.02% |
26,924
-5,609
| -17% | -$282K |
2025 Q4
2 quarters
|
|
302
Altria Group
MO
$120B
| $1.35M | 0.02% |
18,732
+2,731
| +17% | +$191K |
2025 Q4
2 quarters
|
|
303
Rio Tinto
RIO
$153B
| $1.35M | 0.02% |
14,182
+1,907
| +16% | +$193K |
2025 Q4
2 quarters
|
|
304
Cencora
COR
$62B
| $1.34M | 0.02% |
4,738
-2,110
| -31% | -$608K |
2025 Q4
2 quarters
|
|
305
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
$6.17B
| $1.34M | 0.02% |
24,031
+102
| +0.4% | +$5.53K |
2025 Q4
2 quarters
|
|
306
Pfizer
PFE
$162B
| $1.31M | 0.02% |
54,563
+5,818
| +12% | +$152K |
2025 Q4
2 quarters
|
|
307
Prudential Financial
PRU
$39.1B
| $1.31M | 0.02% |
12,111
+4,372
| +56% | +$445K |
2025 Q4
2 quarters
|
|
308
iShares Top 20 U.S. Stocks ETF
TOPT
$781M
| $1.27M | 0.02% |
38,730
+4,146
| +12% | +$135K |
2026 Q1
1 quarter
|
|
309
Danaher
DHR
$156B
| $1.26M | 0.02% |
6,615
+1,165
| +21% | +$212K |
2025 Q4
2 quarters
|
|
310
Shopify
SHOP
$231B
| $1.26M | 0.02% |
11,015
-822
| -7% | -$93.8K |
2025 Q4
2 quarters
|
|
311
Boston Scientific
BSX
$63.5B
| $1.25M | 0.01% |
29,374
-90,412
| -75% | -$4.91M |
2025 Q4
2 quarters
|
|
312
State Street Energy Select Sector SPDR ETF
XLE
$42.5B
| $1.22M | 0.01% |
23,026
+4,695
| +26% | +$268K |
2025 Q4
2 quarters
|
|
313
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.27B
| $1.22M | 0.01% |
52,667
-6,981
| -12% | -$161K |
2025 Q4
2 quarters
|
|
314
Vertex Pharmaceuticals
VRTX
$129B
| $1.19M | 0.01% |
2,397
+2
| +0.1% | +$886 |
2025 Q4
2 quarters
|
|
315
Shell
SHEL
$289B
| $1.19M | 0.01% |
15,293
+2,657
| +21% | +$229K |
2025 Q4
2 quarters
|
|
316
VanEck Emerging Markets High Yield Bond ETF
HYEM
$511M
| $1.19M | 0.01% |
58,965
+5,245
| +10% | +$105K |
2026 Q1
1 quarter
|
|
317
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
| $1.15M | 0.01% |
5,841
+139
| +2% | +$26.9K |
2025 Q4
2 quarters
|
|
318
Ferrari
RACE
$68.3B
| $1.15M | 0.01% |
3,091
-367
| -11% | -$128K |
2025 Q4
2 quarters
|
|
319
CVS Health
CVS
$112B
| $1.15M | 0.01% |
11,120
+5,022
| +82% | +$448K |
2025 Q4
2 quarters
|
|
320
iShares Bloomberg Roll Select Commodity Strategy ETF
CMDY
$743M
| $1.15M | 0.01% |
20,746
| – | – |
2026 Q1
1 quarter
|
|
321
Schwab US Large- Cap ETF
SCHX
$75.3B
| $1.14M | 0.01% |
38,675
+6,271
| +19% | +$179K |
2025 Q4
2 quarters
|
|
322
Vanguard Financials ETF
VFH
$13.1B
| $1.13M | 0.01% |
8,615
-2
| -0% | -$255 |
2025 Q4
2 quarters
|
|
323
Sandisk
SNDK
$215B
| $1.13M | 0.01% |
+495
| New | +$707K |
2026 Q2
0 quarters
|
|
324
Banco Bilbao Vizcaya Argentaria
BBVA
$144B
| $1.12M | 0.01% |
44,705
+8,826
| +25% | +$201K |
2025 Q4
2 quarters
|
|
325
JPMorgan Equity Premium Income ETF
JEPI
$45.8B
| $1.12M | 0.01% |
19,808
+8,369
| +73% | +$473K |
2025 Q4
2 quarters
|
|
Similar funds
HCM
MWM
DKCM
IGAM
FLPIM
MAM
AIM
SBH
OpenArc Corporate Advisory's Q2 2026 Portfolio in Review
As of Q2 2026, OpenArc Corporate Advisory held 833 positions worth $8.41B, up 20% from $6.98B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
OpenArc Corporate Advisory deployed $539M of net new capital in Q2 2026, opening 117 new positions and adding to 380 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 437,245 shares worth $179M.
By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 57% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was iShares A.I. Innovation and Tech Active ETF, an estimated $119M trimmed.
- OpenArc Corporate Advisory's largest Q2 2026 buy was iShares Russell 1000 ETF: 437,245 shares worth $179M.
- OpenArc Corporate Advisory added most to Vanguard Russell 1000 Value ETF in Q2 2026, an estimated $55.3M increase.
- OpenArc Corporate Advisory's biggest Q2 2026 reduction was iShares A.I. Innovation and Tech Active ETF, cutting an estimated $119M.
- OpenArc Corporate Advisory fully exited Kiniksa Pharmaceuticals in Q2 2026, selling an estimated $2.33M.
- OpenArc Corporate Advisory's ten largest holdings make up 33% of its $8.41B portfolio in Q2 2026.
- OpenArc Corporate Advisory opened 117 new positions and closed 44 in Q2 2026.
- OpenArc Corporate Advisory's portfolio value rose 20% quarter-over-quarter to $8.41B.
Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.